Roche Holding AG (OTCMKTS:RHHBY) Given Average Recommendation of "Hold" by Brokerages

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have received an average recommendation of "Hold" from the eight research firms that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have issued a strong buy rating on the company.

Several equities research analysts have issued reports on RHHBY shares. Morgan Stanley initiated coverage on shares of Roche in a research note on Wednesday, February 12th. They issued an "equal weight" rating on the stock. HSBC lowered Roche from a "buy" rating to a "hold" rating in a report on Monday. Sanford C. Bernstein raised Roche to a "strong-buy" rating in a report on Thursday, January 30th. UBS Group upgraded shares of Roche from a "hold" rating to a "strong-buy" rating in a report on Thursday, February 13th. Finally, Hsbc Global Res downgraded shares of Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of RHHBY. Moloney Securities Asset Management LLC increased its stake in shares of Roche by 53.8% during the first quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company's stock worth $1,672,000 after purchasing an additional 14,245 shares during the period. Altrius Capital Management Inc lifted its holdings in shares of Roche by 3.6% during the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after buying an additional 6,545 shares in the last quarter. Riverbridge Partners LLC grew its stake in shares of Roche by 6.7% in the first quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock valued at $1,557,000 after acquiring an additional 2,381 shares in the last quarter. Bard Financial Services Inc. raised its stake in Roche by 25.3% in the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after purchasing an additional 28,050 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Roche by 59.5% during the 1st quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock worth $529,000 after purchasing an additional 4,794 shares in the last quarter.

Roche Stock Performance

Shares of RHHBY traded down $1.19 during mid-day trading on Monday, hitting $39.58. 1,995,483 shares of the company's stock were exchanged, compared to its average volume of 3,054,158. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. Roche has a 52 week low of $29.20 and a 52 week high of $44.31. The company has a 50-day simple moving average of $40.69 and a 200 day simple moving average of $38.62.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.